Michel Dahan

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Carolyn Rucci, attorney-in-fact for Michel Dahan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michel Dahan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. SVP, Chief Operating Officer Common Stock 672,092 $846,836 $1.26 13 May 2024 Direct
Akebia Therapeutics, Inc. SVP, Chief Operating Officer Stock Option (Right to buy) 224,000 31 Jan 2024 Direct

Insider Reports Filed by Michel Dahan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 13 May 2024 1 -$43,898 4 SVP, Chief Operating Officer 14 May 2024, 16:04
AKBA Akebia Therapeutics, Inc. 29 Feb 2024 1 -$13,684 4 SVP, Chief Operating Officer 01 Mar 2024, 17:49
AKBA Akebia Therapeutics, Inc. 27 Feb 2024 1 -$16,331 4 SVP, Chief Operating Officer 29 Feb 2024, 18:02
AKBA Akebia Therapeutics, Inc. 31 Jan 2024 2 $0 4 SVP, Chief Operating Officer 02 Feb 2024, 16:11
AKBA Akebia Therapeutics, Inc. 24 May 2023 3 -$116,760 4 SVP, Chief Operating Officer 25 May 2023, 21:01
AKBA Akebia Therapeutics, Inc. 12 May 2023 1 $0 4 SVP, Chief Operating Officer 16 May 2023, 16:09
AKBA Akebia Therapeutics, Inc. 01 Mar 2023 3 -$17,912 4 SVP, Chief Operating Officer 03 Mar 2023, 07:01
AKBA Akebia Therapeutics, Inc. 27 Feb 2023 1 -$8,205 4 SVP, Chief Operating Officer 01 Mar 2023, 15:06
AKBA Akebia Therapeutics, Inc. 28 Feb 2022 6 -$46,637 4 SVP, Chief Operating Officer 02 Mar 2022, 20:11